チフス熱(Typhoid Fever)の治療薬パイプライン動向（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Typhoid Fever Overview 6
Therapeutics Development 7
Pipeline Products for Typhoid Fever – Overview 7
Pipeline Products for Typhoid Fever – Comparative Analysis 8
Typhoid Fever – Therapeutics under Development by Companies 9
Typhoid Fever – Therapeutics under Investigation by Universities/Institutes 10
Typhoid Fever – Pipeline Products Glance 11
Clinical Stage Products 11
Early Stage Products 12
Unknown Stage Products 13
Typhoid Fever – Products under Development by Companies 14
Typhoid Fever – Products under Investigation by Universities/Institutes 15
Typhoid Fever – Companies Involved in Therapeutics Development 16
Chongqing Zhifei Biological Products Co., Ltd. 16
Novartis AG 17
Prokarium Ltd. 18
Shantha Biotechnics Limited 19
Typhoid Fever – Therapeutics Assessment 20
Assessment by Monotherapy Products 20
Assessment by Combination Products 21
Assessment by Target 22
Assessment by Route of Administration 24
Assessment by Molecule Type 26
Drug Profiles 28
Typhella – Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Typhetec – Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
typhoid + paratyphoid (bivalent) vaccine – Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
typhoid + paratyphoid vaccine – Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
typhoid and paratyphoid fever vaccine – Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
typhoid fever polysaccharide vaccine – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
Vi-CRM197 – Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
Vi-PspA Vaccine – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
ViCRM-197 – Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
Typhoid Fever – Recent Pipeline Updates 38
Typhoid Fever – Dormant Projects 40
Typhoid Fever – Discontinued Products 41
Typhoid Fever – Product Development Milestones 42
Featured News & Press Releases 42
Mar 11, 2013: Prokarium And University Of Birmingham Receive £0.4m Grant To Develop Next Generation Vaccines 42
Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate 42
Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine 43
Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine 43
Aug 30, 2005: Emergent Biosolutions’ Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study 44
Appendix 45
Methodology 45
Coverage 45
Secondary Research 45
Primary Research 45
Expert Panel Validation 45
Contact Us 46
Disclaimer 46